Overexpression of E2F1 blocked the proliferation repression caused by miR-342-3p or miR-377 in glioma cells [12], and E2F1 overexpression conferred resistance to cisplatin in glioma cells [13]. Here, E2F1 is linked to central nervous system cancer.